A Randomized-controlled Trial of Post-operative Opiate Quantities After Urogynecologic Surgery
Postoperative Pain, Opioid Use
About this trial
This is an interventional treatment trial for Postoperative Pain
Eligibility Criteria
Inclusion Criteria:
- Women 18 years or older
Women scheduled to undergo minimally invasive surgery within the urogynecology division at Cleveland Clinic with a plan to stay one night in the hospital afterwards for a benign indication which includes:
- Vaginal hysterectomies with prolapse repair
- Sacrospinous ligament fixations
- Hysteropexy
- Sacrocolpopexy
- Women able to provide consent for research participation and to sign an informed consent
Exclusion Criteria:
- Women with chronic pain or chronic pain syndrome
- Women undergoing concurrent bowel surgery
- Women with pre-operative chronic opiate use
- Inability to comprehend written and/or spoken English
- Inability to provide informed consent
- Inability to take oxycodone
- Inability to take acetaminophen due to allergy or liver disease
- Women will be excluded if they undergo an unplanned laparotomy
- Pain catastrophization score
Sites / Locations
- Cleveland Clinic
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Routine opiate prescription
Decreased opiate prescription
This arm will receive the standard post-discharge prescriptions of ibuprofen, docusate, acetaminophen, and polyethylene glycol. In addition, they will receive the standard amount of post-discharge opiate medications - 28 tablets of oxycodone 5mg.
This arm will receive the standard post-discharge prescriptions of ibuprofen, docusate, acetaminophen, and polyethylene glycol. In addition, they will receive the decreased amount of post-discharge opiate medications - 5 tablets of oxycodone 5mg with a paper prescription for an additional 10 tablets of oxycodone 5mg as a backup for uncontrolled pain.